David B. Elsbree - 15 Sep 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role: Director
Signature: /s/ John Sprague, Attorney-in-Fact
Issuer symbol: TTOO
Transactions as of: 15 Sep 2023
Net transactions value: $0
Form type: 4
Filing time: 11 Oct 2023, 17:00:38 UTC
Previous filing: 13 Oct 2022
Next filing: 17 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TTOO	Common Stock	Options Exercise		+2,300	+42%		7,824	15 Sep 2023	Direct	F1
holding	TTOO	Common Stock						200	15 Sep 2023	By spouse	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TTOO	Restricted Stock Units	Options Exercise	$0	-2,300	-100%	$0.000000^*	0	15 Sep 2023	Common Stock	2,300		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3	On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.